| Identifier | Return Reference | Explanation |
|---|---|---|
| PART IX-A, SUMMARY OF DIRECT CHARITABLE ACTIVITIES: | ADDITIONAL STATEMENT: THE CENTER FOR BRAIN SCIENCES AND METABOLISM, INC. , ("CBSMI"), IS A PRIVATE OPERATING FOUNDATION THAT RECEIVES ANNUAL GRANTS FROM THE CENTER FOR BRAIN SCIENCE AND METABOLISM CHARITABLE TRUST ("TRUST"), EIN: 04-2637647. CBSMI CONDUCTS NUMEROUS RESEARCH PROJECTS INTO BASIC MECHANISMS UNDERLYING THE NERVOUS AND ENDOCRINE SYSTEM REGULATION OF PROTEINS, CALORIES, AND OTHER NUTRIENTS AND MECHANISMS CAUSING OR AFFECTING DISEASES OF HUMANS OR ANIMALS THAT INVOLVE THE BRAIN GLANDS OR METABOLIC REGULATION. THE RESEARCH CONDUCTED IS OF TWO TYPES: BASIC AND CLINICAL. BASIC RESEARCH IS RESEARCH IN ITS PUREST FORM. IT HAS NO PARTICULAR GOAL OTHER THAN KNOWLEDGE ABOUT THE RESEARCH AREA. CLINICAL RESEARCH IS DESIGNED TO TEST ON VOLUNTEERS CERTAIN HYPOTHESIS DEVELOPED IN THE BASIC RESEARCH AREA. FOR EXAMPLE, CBSMI HAS, FOR MANY YEARS STUDIED THE EFFECT OF A SUBSTANCE CALLED SEROTONIN ON THE BRAIN AND THE EFFECT OF MELATONIN IN SLEEP DISORDERS. NEW RESEARCH INCLUDES THE ABILITY OF URIDINE, A COMPOUND NORMALLY PRESENT IN THE BLOOD TO PROMOTE THE GROWTH OF BRAIN CELLS AND TO IMPROVE MEMORY. RESULTS OF THIS BASIC AND CLINICAL RESEARCH ARE IN THE PUBLIC DOMAIN AND NONPROPRIETARY. DISSEMINATION OF THIS DATA FOLLOWS THE CUSTOMARY METHOD: PUBLICATION IN SCIENTIFIC JOURNALS AND PRESENTATION AT SCIENTIFIC CONFERENCES. A REPRESENTATIVE SAMPLE BY TITLLE OF SUCH PUBLICATIONS IS APPENDED HERETO AND INCLUDES ARTICLES PUBLISHED DURING FYE: 10/31/2011. SEE ATTACHED PUBLICATIONS (SENT AS A .PDF ATTACHMENT TO E-FILING). CBSMI HAS SPONSORED NUMEROUS INTERNATIONAL CONFERENCES ON BRAIN SCIENCE, PARTICULARLY ALZHEIMER'S DISEASE, WHICH BRINGS TOGETHER MANY OF THE WORLD'S LEADING SCIENTISTS. CONTRIBUTIONS TO CBSMI ENABLE IT TO SPONSOR ATTENDENCE BY INDIVIDUAL SCIENTISTS, WHO OTHERWISE WOULD BE UNABLE TO ATTEND. PAPERS, BOTH CBSMI SPONSORED AND OTHERS ARE PRESENTED BY THE RESEARCHERS TO THE ATTENDEES. NEW RESEARCH HAS BEEN COMMENCED INTO ALZHEIMER'S INCLUDING THE EFFECT OF COX-2 INHIBITORS (SUCH AS IBUPROFEN). CBSMI ALSO HAS PROJECTS INVOLVING WEIGHT GAIN IN ANTI-PSYCHOTIC DRUGS, 5-HTP (A SEROTONIN PRECURSER), RESVERATROL AND URIDINE-CHOLINE. |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Insurance | 230 | |||
| Meals & Ent. | 1,802 | |||
| Office expense | 2,223 | |||
| Payroll expense | 235 | |||
| Postage | 328 | |||
| Telephone | 1,841 | |||
| Bank charges | 18 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PAYROLL TAXES | 907 |